Form 4: Longeveron Executive Reports Stock Transaction
Insider Transaction (Form 4)
Nataliya Agafonova, Chief Medical Officer of Longeveron Inc., reported a transaction in 2,913 shares of common stock on October 1, 2026.
Summary
- Tax/exercise-price withholding: disposed of 2,913 Class A Common Stock at $2.59 ($7,545) on October 1, 2026; holds 68,778 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Nataliya Agafonova — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Tax/exercise-price withholding | Class A Common Stock | 2,913 | $3 | $7.5K | 68,778 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Tax/exercise-price withholding (2,913 shares) |
Keywords
insider transaction, Form 4, LGVN, Longeveron Inc., neutral, Nataliya Agafonova
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.